NCT02163239

Brief Summary

This study evaluates the use of the FloShield System with the FloShield 10mm reusable Cannula and Oburator during standard robotic laparoscopic single-site surgery. The study will evaluate the compatibility of the FloShield 10mm Cannula and Oburator with the daVinci® Robotic Surgical System during single-site laparoscopic surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2015

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 13, 2014

Completed
9 months until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

September 28, 2015

Status Verified

September 1, 2015

Enrollment Period

6 months

First QC Date

June 10, 2014

Last Update Submit

September 25, 2015

Conditions

Keywords

FloShieldMIDMinimally invasive surgeryMinimally Invasive devicesRobot-assisted Laparoscopic SurgerySingle-site Laparoscopic SurgerySingle Incision Laparoscopic SurgeryCannulaBlunt ObturatorCholecystectomyBenign hysterectomySalpingo-oophorectomy

Outcome Measures

Primary Outcomes (1)

  • Completion rate

    Completion rate is the percentage of users who successfully complete the task without critical errors. A critical error is defined as an error that results in an incorrect or incomplete outcome (Grade 1 and 2). In other words, the completion rate represents the percentage of participants who, when they are finished with the specified task, have an "output" that is correct (Grade 3 - 5). Note: If a participant requires assistance in order to achieve a correct output then the task will be scored as a critical error and the overall completion rate for the task will be affected. A completion rate of 90% is the goal for each task in this usability test.

    1 - 4hr (Initial insertion to final withdrawal of the laparoscope)

Secondary Outcomes (1)

  • Performance

    1 - 4hr (Initial insertion to final withdrawal of the laparoscope)

Study Arms (1)

10mm Cannula

Subjects that are scheduled for a robot-assisted laparoscopic single-incision surgery for cholecystectomy, benign hysterectomy or salpingo-oophorectomy under the care of the study investigator

Device: Cannula and Blunt Obturator

Interventions

The FloShield 10mm Endoscopic Cannula and Blunt Obturator will be used to maintain access to the peritoneal cavity during robot-assisted single site laparoscopic surgery

Also known as: FloShield 10mm Endoscopic Cannula, FRT10C, FloShield Blunt Oburator, FRT10B
10mm Cannula

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects will be recruited from a population of patients who are from the medical practice of the study investigator and who are scheduled to undergo robot-assisted laparoscopic single-incision surgery for cholecystectomy, benign hysterectomy or salpingo-oophorectomy

You may qualify if:

  • Male or female, 18 years or older
  • Scheduled for a laparoscopic single-incision surgery for cholecystectomy, benign hysterectomy or salpingo-oophorectomy under the care of the study investigator
  • Suitable candidate for surgery
  • Is able to read and understand the informed consent form and has voluntarily provided written informed consent

You may not qualify if:

  • Unfit for surgery: concomitant disorders incompatible with the study or surgery (at the discretion of the investigator)
  • Subjects with known allergy (hypersensitivity) to Docusate Sodium
  • Use of Surgiquest AirSeal during the laparoscopic single-site surgery
  • Use of humidified insufflation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baptist Health South Florida

Miami, Florida, 33183, United States

Location

MeSH Terms

Interventions

Cannula

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Study Officials

  • Wayne Poll, MD

    Minimally Invasive Devices

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2014

First Posted

June 13, 2014

Study Start

March 1, 2015

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

September 28, 2015

Record last verified: 2015-09

Locations